- NSE
- VENUSREM
- BSE
- 526953
- ISIN
- INE411B01019
VENUS REMEDIES
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,444.60
+₹0.70 (+0.05%)
NSE close ·
VENUS REMEDIES closed at ₹1,444.60 on 12 Nov 2026, up 0.05% on the day, and is up 168.64% over the past year.
Price history
Between 12 Nov 2025 and 12 Nov 2026, the closing price ranged from ₹537.75 to ₹1,947.00.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,931 Cr
- Industry P/E
- 35.0
- Dividend yield
- 0.69%
Market cap and yield at the 12 Nov 2026 close. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Jun 2026 | ₹181 Cr | ₹22.97 Cr | — | ₹17.18 |
Armor risk check
VENUS REMEDIES moves about 4× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is VENUS REMEDIES's share price today?
VENUS REMEDIES (NSE: VENUSREM) closed at ₹1,444.60 on 12 Nov 2026, up 0.05% from the previous close of ₹1,443.90. It traded between ₹1,412.10 and ₹1,460.00 that day.
What are VENUS REMEDIES's 52-week high and low?
Over the last 52 weeks VENUS REMEDIES traded between ₹516.50 and ₹2,044.30, adjusted for splits and bonuses.
What are VENUS REMEDIES's NSE symbol, BSE code and ISIN?
VENUS REMEDIES has NSE symbol VENUSREM, BSE code 526953, ISIN INE411B01019.
How has VENUS REMEDIES performed over 1, 3 and 5 years?
VENUS REMEDIES's share price return: 1Y +168.64%, 3Y +64.45% a year, 5Y +24.51% a year. Dividends are not included.
Does VENUS REMEDIES pay a dividend?
Yes. VENUS REMEDIES's latest dividend went ex on 7 Aug 2026: Final · ₹10.00 per share. Dividends over the past year come to a yield of 0.69% at the latest close.
What is VENUS REMEDIES's market cap?
VENUS REMEDIES's market cap is ₹1,931 Cr at the close on 12 Nov 2026.
Which sector is VENUS REMEDIES in?
VENUS REMEDIES is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how VENUS REMEDIES fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app